Evaluation of Appetite-Stimulating Hormones in Prepubertal Children With Epilepsy During Topiramate Treatment

Rosenfeld, 1997, Topiramate: A review of preclinical, pharmacokinetic, and clinical data, Clin Ther, 19, 1294, 10.1016/S0149-2918(97)80006-9 Langtry, 1997, Topiramate: A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy, Drugs, 54, 752, 10.2165/00003495-199754050-00009 Verrotti, 2011, Topiramate-induced weight loss: A review, Epilepsy Res, 95, 189, 10.1016/j.eplepsyres.2011.05.014 Genc, 2010, Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment, J Clin Neurosci, 17, 1256, 10.1016/j.jocn.2010.01.045 Li, 2009, Effects of topiramate on weight and metabolism in children with epilepsy, Acta Paediatr Scand, 98, 1521, 10.1111/j.1651-2227.2009.01349.x 1989, Proposal for revised classification of epilepsies and epileptic syndromes, Epilepsia, 30, 389, 10.1111/j.1528-1157.1989.tb05316.x Klein, 2008, Topiramate, nutrition and weight change: A prospective study, J Neurol Neurosurg Psychiatry, 79, 590, 10.1136/jnnp.2007.136929 Bray, 2003, A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity, Obes Res, 11, 722, 10.1038/oby.2003.102 Wilkes, 2005, Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats, Am J Physiol Endocrinol Metab, 288, E617, 10.1152/ajpendo.00437.2004 Richard, 2000, Influence of topiramate in the regulation of energy balance, Nutrition, 16, 961, 10.1016/S0899-9007(00)00452-4 Liang, 2005, Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice, Diabetes Obes Metab, 7, 360, 10.1111/j.1463-1326.2004.00403.x Bray, 1998, The Mona Lisa hypothesis in the time of leptin, Recent Prog Horm Res, 53, 95 Narula, 2010, Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial, Schizophr Res, 118, 218, 10.1016/j.schres.2010.02.001 Husum, 2003, Topiramate normalizes hippocampal NPY-LI in flinders sensitive line “depressed” rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: Implications for mood-stabilizing and weight loss-inducing effects, Neuropsychopharmacology, 28, 1292, 10.1038/sj.npp.1300178 Lalonde, 2004, Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice, Physiol Behav, 80, 415, 10.1016/j.physbeh.2003.08.013 Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230 Ramos, 2005, Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation, Nutrition, 21, 269, 10.1016/j.nut.2004.06.021 Astrup, 2004, Topiramate: Long-term maintenance of weight loss induced by a low-calorie diet in obese subjects, Obes Res, 12, 1658, 10.1038/oby.2004.206 Ben-Menachem, 2003, Predictors of weight loss in adults with topiramate-treated epilepsy, Obes Res, 11, 556, 10.1038/oby.2003.78